|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|

This excerpt from an article on TradingView provides an analysis of XRP's price action using Elliott Wave theory. The article suggests that XRP is trading in a familiar range on the higher time frame and has pulled back from the 38.2% Fibonacci retracement area, a level often associated with wave 4 corrections in Elliott Wave terminology.
At the time of writing, XRP is down by more than 2% and has slipped below the $2.20 mark.
The ongoing pullback is part of a larger wave 4 correction. From this zone, a further move up is possible, with chances for XRP to form another higher high. However, a deeper retracement cannot be excluded. In the event of another leg down, support between $1.22 and $1.34 would become the next area to watch.
The $1.21 level is pivotal. A break below this point would significantly weaken the bullish case, suggesting a shift toward a more bearish outlook.
As long as XRP holds above the current upper support levels, the potential for an upward breakout remains. Possible targets in this scenario include $5.00, $5.65, and even $6.60.
While some traders speculate about XRP reaching $10 or more, such possibilities are considered low-probability outliers without clear structural support at this stage. Any extended fifth wave would be unusual and would require strong confirmation.
To continue the bullish pattern, a break below the short-term support at $2.12 could lead to a reset of the current wave count and signal a larger flat correction.output: The cryptocurrency markets are known for their volatility, which can quickly shift the market narrative and invalidated any technical analysis.
The article provides an interesting perspective on XRP's price action using Elliott Wave theory. However, it's important to note that Elliott Wave analysis is subjective and can vary among traders.
Additionally, while the article mentions the possibility of further price gains, it also highlights the risks of a deeper retracement.
Traders will need to closely monitor key support and resistance levels, as well as any changes in technical indicators, to adapt their trading strategies accordingly.
Finally, while some traders speculate about XRP reaching $10 or more, such possibilities are considered low-probability outliers without clear structural support at this stage. Any extended fifth wave would be unusual and would require strong confirmation.
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
- Datavecta Forges Global Community Ecosystem to Power International Growth Through Advanced SEO Strategy
- Sep 30, 2026 at 07:55 pm
- Datavecta is building a global community ecosystem to enhance international growth, leveraging advanced SEO strategies and technology-driven services for a connected intelligent trading future.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
































